MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Biotie Therapies Oyj Company Profile (NASDAQ:BITI)

Consensus Ratings for Biotie Therapies Oyj (NASDAQ:BITI) (?)
Ratings Breakdown: 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $28.40 (10.08% upside)

Analysts' Ratings History for Biotie Therapies Oyj (NASDAQ:BITI)
Show:
DateFirmActionRatingPrice TargetActions
3/21/2016RBC CapitalDowngradeOutperform -> Sector Perform$35.00 -> $25.60View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Roth CapitalDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015JMP SecuritiesInitiated CoverageOutperform$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Biotie Therapies Oyj (NASDAQ:BITI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/20/2015($1.10)($1.77)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Biotie Therapies Oyj (NASDAQ:BITI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.87)($0.87)($0.87)
Q2 20161($0.87)($0.87)($0.87)
Q3 20161($0.87)($0.87)($0.87)
Q4 20161($0.87)($0.87)($0.87)
(Data provided by Zacks Investment Research)
Dividend History for Biotie Therapies Oyj (NASDAQ:BITI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Biotie Therapies Oyj (NASDAQ:BITI)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Biotie Therapies Oyj (NASDAQ:BITI)
DateHeadline
06/21/16 09:02 AMChange in Biotie Therapies' Financial Reporting Calendar 2016 - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 21 June 2016, at 5.00 p.m. Change in Biotie Therapies` Financial Reporting Calendar 2016 Due to Biotie Therapies Corp. (Nasdaq Helsinki: ...
06/10/16 12:02 AMTRUSTEE APPOINTED FOR THE REDEMPTION PROCEEDINGS CONCERNING BIOTIE'S MINORITY SHARES - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 10 June 2016, at 8.00 a.m. (EET) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, JAPAN, AUSTRALIA, SOUTH ...
05/26/16 10:10 AMBiotie Therapies Oyj :BITI-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 -
05/18/16 10:22 AMNORDEA BANK FINLAND PLC'S MARKET-MAKING FOR BIOTIE THERAPIES CORP.'S SHARE ENDS - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 18 May 2016, at 6.20 p.m. (EET) NORDEA BANK FINLAND PLC`S MARKET-MAKING FOR BIOTIE THERAPIES CORP.`S SHARE ENDS Biotie Therapies Corp. (" ...
05/12/16 03:11 AM4:11 am Biotie Therapies reports Q1 results -
05/12/16 01:03 AMBiotie Interim Report 1 January - 31 March 2016 - [GlobeNewswire] - BIOTIE THERAPIES CORP. INTERIM REPORT May 12, 2016 at 9.00 a.m. Biotie Interim Report 1 January - 31 March 2016 Biotie (Nasdaq Helsinki: BTH1V; NASDAQ: BITI) announces its interim ...
05/03/16 08:33 AMRESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. AND ORGANIZATION OF THE BOARD - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 3 May 2016 at 4.30 p.m. RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. AND ORGANIZATION OF THE BOARD The Annual General Meeting of Biotie ...
05/02/16 08:43 AMFINAL RESULTS OF THE SUBSEQUENT OFFER PERIOD OF ACORDA'S TENDER OFFER FOR ALL SECURITIES IN BIOTIE - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 2 May 2016, at 4.40 p.m. (EET) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, JAPAN, AUSTRALIA, SOUTH ...
05/02/16 08:02 AMFinal Results of the Subsequent Offer Period of Acorda Therapeutics' Tender Offer for All of the Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. - [Business Wire] - The subsequent offer period under the voluntary public tender offer by Acorda Therapeutics, Inc. to purchase all of the issued and outstanding shares , American Depositary Shares , stock options, share units and warrants in Biotie Therapies Corp that are not owned by Biotie or any of its subsidiaries commenced on 14 April 2016 and expired on 28 April 2016 .
04/20/16 08:52 AMACORDA THERAPEUTICS TO COMMENCE A COMPULSORY REDEMPTION PROCEEDING IN RESPECT OF THE REMAINING BIOTIE THERAPIES CORP. SHARES - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 20 April 2016, at 4.50 p.m. (EET) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, JAPAN, AUSTRALIA, SOUTH ...
04/18/16 03:01 PMCompletion of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. and Matters Related Thereto - [Business Wire] - On 11 March 2016, Acorda Therapeutics, Inc. commenced a voluntary public tender offer to purchase all of the issued and outstanding shares , American Depositary Shares , stock options , share units and warrants in Biotie Therapies Corp that are not owned by Biotie or any of its subsidiaries .
04/18/16 01:32 PMRoth Capital Terminates Biotie Therapies Oyj (ADR)(NASDAQ:BITI) - Market Digest - Roth Capital Terminates Biotie Therapies Oyj (ADR)(NASDAQ:BITI)Market DigestBrokerage firm Roth Capital Terminates its rating on Biotie Therapies Oyj (ADR)(NASDAQ:BITI). In a research note issued to the investors, the brokerage major Removes the price-target to $ per share. Previously, the analysts had a Neutral rating on the ...
04/13/16 01:35 PMBiotie Therapies Oyj: FINAL RESULTS OF ACORDA'S TENDER OFFER AND COMMENCEMENT OF A SUBSEQUENT OFFER PERIOD - the "Equity Interests") in Biotie Therapies Corp (Nasdaq Helsinki: BTH1V; Nasdaq: BITI) ("Biotie" or the "Company") that are not owned by Biotie or any of its subsidiaries (the "Tender Offer"). The Tender Offer expired on 8 April 2016. Biotie has today ...
04/13/16 09:13 AMFINAL RESULTS OF ACORDA'S TENDER OFFER AND COMMENCEMENT OF A SUBSEQUENT OFFER PERIOD - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 13 April 2016, at 5.10 p.m (EET) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, JAPAN, AUSTRALIA, SOUTH ...
04/13/16 08:00 AMFinal Results of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. and Commencement of a Subsequent Offer - [Business Wire] - On 11 March 2016, Acorda Therapeutics, Inc. commenced a voluntary public tender offer to purchase all of the issued and outstanding shares , American Depositary Shares , stock options , share units and warrants in Biotie Therapies Corp that are not owned by Biotie or any of its subsidiaries .
04/12/16 08:22 AMDisclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE April 12, 2016 at 4.20 p.m. Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act Biotie Therapies Corp. (Nasdaq Helsinki ...
04/12/16 01:02 AMINVITATION TO THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 12 April 2016 at 9.00 a.m. (EET) INVITATION TO THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. Notice is given to the shareholders ...
04/11/16 09:02 AMACORDA ANNOUNCES PRELIMINARY TENDER OFFER RESULTS AND ACCEPTANCE OF THE SECURITIES IN BIOTIE TENDERED IN TENDER OFFER - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 11 April 2016, at 5.00 pm (EET) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, JAPAN, AUSTRALIA, SOUTH ...
04/11/16 07:59 AMAcorda Therapeutics Announces Preliminary Tender Offer Results and Acceptance of the Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. Tendered in Tender Offer - [Business Wire] - On 11 March 2016, Acorda Therapeutics, Inc. commenced a voluntary public tender offer to purchase all of the issued and outstanding shares , American Depositary Shares , stock options , share units and warrants in Biotie Therapies Corp that are not owned by Biotie or any of its subsidiaries .
03/27/16 12:17 PMRBC Capital Downgrades Biotie Therapies Oyj (ADR) to Sector Perform with Price Target $25.60 - Street Edition - RBC Capital Downgrades Biotie Therapies Oyj (ADR) to Sector Perform with Price Target $25.60Street EditionBrokerage firm RBC Capital Downgrades its rating on Biotie Therapies Oyj (ADR)(NASDAQ:BITI). In a research note issued to the investors, the brokerage major Lowers the price-target to $25.60 per share. The shares have been rated Sector Perform.
03/26/16 12:04 PMBIOTIE THERAPIES CORP. Financials -
03/23/16 12:00 PMACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER ... - GlobeNewswire (press release) - ACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER ...GlobeNewswire (press release)Biotie Therapies Corp. ("Biotie" or the "Company") announced on 10 March 2016 that the Finnish Financial Supervisory Authority has approved the tender offer document (the "Tender Offer Document") relating to the voluntary public tender offer by Acorda ...
03/23/16 12:00 PMRevenue Update on Biotie Therapies Oyj (ADR)(NASDAQ:BITI) - Street Edition - Revenue Update on Biotie Therapies Oyj (ADR)(NASDAQ:BITI)Street EditionBiotie Therapies Oyj (ADR)(NASDAQ:BITI) announced the earnings results for Fiscal Year 2015 and Q4. The results came in during Pre-market on Mar 18, 2016. Company reported revenue of $846.37K. Analysts estimated a revenue of $840.00K. Earnings ...
03/23/16 09:18 AMBiotie Therapies Oyj :BITI-US: Earnings Analysis: Q4, 2015 By the Numbers -
03/22/16 01:06 PMBiotie Therapies Oyj :BITI-US: Earnings Analysis: 2015 By the Numbers -
03/22/16 12:39 PMACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER ... - PharmiWeb.com (press release) - ACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER ...PharmiWeb.com (press release)Biotie Therapies Corp. ("Biotie" or the "Company") announced on 10 March 2016 that the Finnish Financial Supervisory Authority has approved the tender offer document (the "Tender Offer Document") relating to the voluntary public tender offer by Acorda ...and more »
03/22/16 07:22 AMACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER ON 22 MARCH 2016 - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 22 March 2016, at 2.20 pm (EET) ACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER FOR ALL OF THE ISSUED ...
03/22/16 07:03 AMAcorda Therapeutics Supplements the Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Co - [Business Wire] - As announced on 10 March 2016, Acorda Therapeutics, Inc. has on 11 March 2016 commenced a voluntary public tender offer to purchase all of the issued and outstanding shares , American Depositary Shares , stock options , share units and warrants in Biotie Therapies Corp.
03/22/16 03:02 AMBiotie's Financial Statement Report and Corporate Governance Statement 2015 published - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE March 22, 2016 at 10 a.m. Biotie`s Financial Statement Report and Corporate Governance Statement 2015 published Biotie Therapies Corp.`s (Nasdaq Helsinki ...
03/21/16 12:54 PMBiotie Therapies Oyj (ADR) (BITI) is Downgraded by RBC Capital Mkts to Sector Perform, Lowers Price Target to $ 25.60 - Los Angeles Mirror - Biotie Therapies Oyj (ADR) (BITI) is Downgraded by RBC Capital Mkts to Sector Perform, Lowers Price Target to $ 25.60Los Angeles MirrorBiotie Therapies Oyj (ADR) (BITI) was Downgraded by RBC Capital Mkts to ” Sector Perform” while Lowering the Price Target of the company shares to $ 25.60 from a previous price target of $35 . Earlier the firm had a rating of “Outperform ” on the ...and more »
03/21/16 05:11 AMBiotie Therapies downgraded by RBC Capital Mkts -
03/18/16 08:43 AMACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER ON 18 MARCH 2016 - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 18 March 2016, at 3.40 p.m. (EET) ACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER ON 18 MARCH 2016 ...
03/18/16 08:03 AMAcorda Therapeutics Supplements Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies on 18 - [Business Wire] - As announced on 10 March 2016, Acorda Therapeutics, Inc. has on 11 March 2016 commenced a voluntary public tender offer to purchase all of the issued and outstanding shares , American Depositary Shares , stock options , share units and warrants in Biotie Therapies Corp.
03/18/16 02:03 AMBiotie Financial Statement Release 2015 - [GlobeNewswire] - BIOTIE THERAPIES CORP. FINANCIAL STATEMENT RELEASE March 18, 2016 at 9.00 a.m. Biotie Financial Statement Release 2015 Biotie (Nasdaq Helsinki BTH1V; NASDAQ: BITI) announces its financial ...
03/10/16 09:47 AMTHE FINNISH FINANCIAL SUPERVISORY AUTHORITY HAS APPROVED THE TENDER OFFER DOCUMENT, ACORDA WILL COMMENCE THE VOLUNTARY PUBLIC TENDER OFFER ON 11 MARCH 2016 - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 10 March 2016, 5.45 p.m. THE FINNISH FINANCIAL SUPERVISORY AUTHORITY HAS APPROVED THE TENDER OFFER DOCUMENT, ACORDA WILL COMMENCE THE VOLUNTARY ...
03/10/16 07:40 AMAcorda Therapeutics, Inc. Will Commence the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. on 11 March 2016 - [Business Wire] - As announced on 19 January 2016, Acorda Therapeutics, Inc. and Biotie Therapies Corp. have on 19 January 2016 entered into a Combination Agreement under which they agree to combine the operations of Acorda and Biotie.
03/09/16 11:55 AMBiotie Therapies Corp. (NASDAQ:BITI) Updated Price Targets - Share Trading News - Biotie Therapies Corp. (NASDAQ:BITI) Updated Price TargetsShare Trading NewsRecently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Biotie Therapies Corp. (NASDAQ:BITI). The most recent broker reports which have been released note that 0 analysts ...
03/04/16 11:18 AMSTATEMENT OF THE BOARD OF DIRECTORS OF BIOTIE THERAPIES CORP. REGARDING THE VOLUNTARY PUBLIC TENDER OFFER BY ACORDA THERAPEUTICS, INC. - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 4 March 2016, 7.15 p.m. STATEMENT OF THE BOARD OF DIRECTORS OF BIOTIE THERAPIES CORP. REGARDING THE VOLUNTARY PUBLIC TENDER OFFER BY ACORDA THERAPEUTICS, ...
03/04/16 10:42 AMCHANGE IN THE TIME OF BIOTIE THERAPIES' ANNUAL GENERAL MEETING 2016 - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 4 March 2016, 6.40 p.m. CHANGE IN THE TIME OF BIOTIE THERAPIES` ANNUAL GENERAL MEETING 2016 Due to the announced tender offer by Acorda Therapeutics, ...
03/03/16 01:04 AMACORDA HAS FILED THE DRAFT TENDER OFFER DOCUMENT RELATING TO ITS PUBLIC TENDER OFFER FOR BIOTIE THERAPIES WITH THE FINNISH FINANCIAL SUPERVISORY AUTHORITY - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 3 March 2016, 9.00 a.m. ACORDA HAS FILED THE DRAFT TENDER OFFER DOCUMENT RELATING TO ITS PUBLIC TENDER OFFER FOR BIOTIE THERAPIES WITH THE FINNISH ...
03/03/16 12:30 AMAcorda Has Filed Tender Offer Document Relating to Public Tender Offer For Biotie Therapies with Finnish Financial Supervisory Authority - [Business Wire] - As announced on January 19, 2016, Acorda Therapeutics, Inc. and Biotie Therapies Corp. have entered into a Combination Agreement pursuant to which Acorda will make a voluntary public tender offer in Finland and in the United States to acquire all of the issued and outstanding shares, American Depositary Shares, stock options, share units and warrants in Biotie that are not owned by Biotie or any of ...
02/26/16 11:30 AMBiotie Therapies Corp. (NASDAQ:BITI) Recent Analyst Updates - Risers & Fallers - Biotie Therapies Corp. (NASDAQ:BITI) Recent Analyst UpdatesRisers & FallersA number of investment brokers have recently updated their price targets on shares of Biotie Therapies Corp. (NASDAQ:BITI). According to the latest broker reports outstanding on Friday 26th of February, 0 analysts have a rating of “strong buy”, 1 ...
02/25/16 11:26 AMChanges To Broker Targets On Biotie Therapies Corp. (NASDAQ:BITI) - Share Trading News - Changes To Broker Targets On Biotie Therapies Corp. (NASDAQ:BITI)Share Trading NewsBiotie Therapies Oyj is a Finland-based drug development company focused on developing products for neurodegenerative and psychiatric disorders. The Company's lead market product is Selincro (nalmefene), a therapeutic for alcohol dependence that is ...
02/17/16 01:04 AMU.S. antitrust regulation waiting period relating to tender offer has expired - [GlobeNewswire] - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 17 February 2016, 09:00 a.m. U.S. antitrust regulation waiting period relating to tender offer has expired Biotie Therapies Corp. (" Biotie ...
02/17/16 12:30 AMAcorda Announces Expiration of the Hart-Scott-Rodino Waiting Period for Its Tender Offer for Biotie Therapies - [Business Wire] - Acorda Therapeutics, Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended , for its tender offer for Biotie Therapies Corp.
01/20/16 03:25 PMBiotie Therapies Soars on $363M Buyout Deal with Acorda -
01/20/16 03:25 PMBiotie Therapies Soars on $363M Buyout Deal with Acorda -
01/20/16 07:15 AMBiotie Therapies (BITI) Catches Eye: Stock Moves Up 86.5% -
01/20/16 07:15 AMBiotie Therapies (BITI) Catches Eye: Stock Moves Up 86.5% -
01/19/16 08:40 AMAcorda Therapeutics To Acquire Biotie Therapies To Boost Its Parkinson's Disease Therapeutic Development -
About Biotie Therapies Oyj

Biotie Therapies Oyj logoBiotie Therapies Oyj is a Finland-based drug development company focused on developing products for neurodegenerative and psychiatric disorders. The Company's lead market product is Selincro (nalmefene), a therapeutic for alcohol dependence that is rolled out across Europe by its partner Lundbeck. Its product pipeline includes tozadenant, a therapeutic for Parkinson's disease that is in Phase Three development; and two additional compounds in Phase Two development that treat cognitive disorders, namely: SYN120, an orally administered compound therapeutic for Parkinson's disease dementia, and BTT1023, a human monoclonal antibody targeting compound therapeutic for primary sclerosing cholangitis. The Company operates as a subsidiary of Biotie Therapies Corp.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BITI
  • CUSIP:
Key Metrics:
  • Previous Close: $25.80
  • 50 Day Moving Average: $26.42
  • 200 Day Moving Average: $22.73
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Current Quarter EPS Consensus Estimate: $-3.30 EPS
Additional Links:
Biotie Therapies Oyj (NASDAQ:BITI) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha